Sevelamer hydrochloride 800 MG Oral Tablet — RxCUI 857224
RxNorm drug concept · Semantic clinical drug
RxCUI 857224
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI857224
Official nameSevelamer hydrochloride 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assevelamer HCl 800 MG Oral Tablet
FDA products mapped13
Package NDCs mapped16
Reported Medicaid activity (SDUD)12,915 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sevelamer: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When your kidneys aren't working properly, they can't remove phosphorus from your blood the way they normally would. Dialysis helps, but it doesn't always bring phosphorus down eno...
- What exactly does sevelamer do, and why do I need it if I'm on dialysis?
- Yes, timing really matters here. Sevelamer needs to be taken with each meal because it works by binding to phosphate in the food you're eating right then. If you take it without fo...
- Does it matter when I take it — can I just take all my doses at once?
🕸️ Concept Web — How Sevelamer hydrochloride 800 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sevelamer hydrochloride 800 MG Oral Tablet
RxCUI 857224 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Sevelamer
214824IN -
Sevelamer hydrochloride
237125PIN
-
Sevelamer
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
RenaGel
135118BN
-
RenaGel
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sevelamer Oral Tablet
374639SCDF -
Sevelamer hydrochloride Oral Tablet
2645341SCDFP -
Sevelamer Oral Product
1159078SCDG -
Sevelamer Pill
1159079SCDG -
Sevelamer hydrochloride Oral Product
2663265SCDGP -
Sevelamer hydrochloride Pill
2661575SCDGP -
Sevelamer Oral Tablet [RenaGel]
368161SBDF -
Sevelamer hydrochloride Oral Tablet [RenaGel]
2657007SBDFP - +5 more in this family
-
Sevelamer Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sevelamer hydrochloride 800 MG
857223SCDC -
Sevelamer hydrochloride 800 MG Oral Tablet [RenaGel]
857226SBD -
Sevelamer hydrochloride 800 MG [RenaGel]
857225SBDC
-
Sevelamer hydrochloride 800 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sevelamer hydrochloride 800 MG
SCDC · 857223 -
Sevelamer Oral Tablet
SCDF · 374639 -
Sevelamer hydrochloride Oral Tablet
SCDFP · 2645341 -
Sevelamer Oral Product
SCDG · 1159078 -
Sevelamer Pill
SCDG · 1159079 -
Sevelamer hydrochloride Oral Product
SCDGP · 2663265 -
Sevelamer hydrochloride Pill
SCDGP · 2661575
Brand-Name Concepts
-
Sevelamer hydrochloride 800 MG Oral Tablet [RenaGel]
SBD · 857226 -
Sevelamer hydrochloride 800 MG [RenaGel]
SBDC · 857225 -
Sevelamer Oral Tablet [RenaGel]
SBDF · 368161 -
Sevelamer hydrochloride Oral Tablet [RenaGel]
SBDFP · 2657007 -
RenaGel Oral Product
SBDG · 1180736 -
RenaGel Pill
SBDG · 1180737 -
RenaGel
BN · 135118
📦 FDA Products & Package NDCs
13 products · 16 package NDCs
16 package NDCs map to RxCUI 857224 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-7209-06 | 50 BLISTER PACK in 1 CARTON (0904-7209-06) / 1 TABLET, FILM... | sevelamer hydrochloride | Major Pharmaceuticals | 2024-08-19 |
| 33342-0241-65 | 360 TABLET, FILM COATED in 1 BOTTLE (33342-241-65) | Sevelamer Hydrochloride | Macleods Pharmaceuticals Limited | 2023-05-26 |
| 33342-0242-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-242-07) | Sevelamer Hydrochloride | Macleods Pharmaceuticals Limited | 2023-05-26 |
| 33342-0242-57 | 180 TABLET, FILM COATED in 1 BOTTLE (33342-242-57) | Sevelamer Hydrochloride | Macleods Pharmaceuticals Limited | 2023-05-26 |
| 55154-2647-00 | 10 BLISTER PACK in 1 BAG (55154-2647-0) / 1 TABLET, FILM CO... | sevelamer hydrochloride | Cardinal Health 107, LLC | 2025-02-25 |
| 59651-0087-36 | 360 TABLET, FILM COATED in 1 BOTTLE (59651-087-36) | SEVELAMER HYDROCHLORIDE | Aurobindo Pharma Limited | 2023-07-11 |
| 59651-0088-18 | 180 TABLET, FILM COATED in 1 BOTTLE (59651-088-18) | SEVELAMER HYDROCHLORIDE | Aurobindo Pharma Limited | 2023-07-11 |
| 60687-0449-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-449-01) / 1 TAB... | Sevelamer Hydrochloride | American Health Packaging | 2020-01-22 |
| 68462-0446-26 | 360 TABLET, FILM COATED in 1 BOTTLE (68462-446-26) | sevelamer hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2019-02-08 |
| 68462-0446-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68462-446-30) | sevelamer hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2019-02-08 |
| 68462-0447-18 | 180 TABLET, FILM COATED in 1 BOTTLE (68462-447-18) | sevelamer hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2019-02-08 |
| 68462-0447-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68462-447-30) | sevelamer hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2019-02-08 |
| 70710-2058-08 | 180 TABLET, FILM COATED in 1 BOTTLE (70710-2058-8) | Sevelamer Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2025-03-01 |
| 70748-0173-26 | 180 TABLET in 1 BOTTLE (70748-173-26) | Sevelamer hydrochloride | Lupin Pharmaceuticals, Inc. | 2022-02-25 |
| 72162-2501-02 | 180 TABLET, FILM COATED in 1 BOTTLE (72162-2501-2) | Sevelamer Hydrochloride | Bryant Ranch Prepack | 2025-05-15 |
| 72603-0148-01 | 180 TABLET, FILM COATED in 1 BOTTLE (72603-148-01) | sevelamer hydrochloride | NorthStar RxLLC | 2023-05-23 |
Observed labelers:
Glenmark Pharmaceuticals Inc., USA (4) ·
Macleods Pharmaceuticals Limited (3) ·
Aurobindo Pharma Limited (2) ·
American Health Packaging (1) ·
Bryant Ranch Prepack (1) ·
Cardinal Health 107, LLC (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.